Skip to main content

tuberculosis Archives

VUMC lands grant to build top-line biosafety facility

Sep. 29, 2022—Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.

Read more


New Clinician Spotlight: Rebecca (Ribka) Berhanu

Mar. 30, 2022—Rebecca Berhanu, MD, assistant professor of Medicine, has joined Vanderbilt's Division of Infectious Diseases as a clinician and researcher.

Read more


Confronting TB resistance

Jun. 11, 2018—Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

Read more


HIV treatment and TB risk

Aug. 4, 2016—Tuberculosis (TB) remains an important public health problem, particularly among people infected with the human immunodeficiency virus (HIV).

Read more


Study explores gene’s role in protecting HIV patients from TB

Mar. 17, 2016—An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12.

Read more


Slight chemical change may improve TB treatments: study

Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.

Read more


Routine TB testing to resume Dec. 16

Dec. 12, 2013—Routine tuberculosis (TB) skin testing for Vanderbilt staff and faculty will resume Monday, Dec. 16, after temporarily being suspended since September due to a national shortage of the TB skin testing solution Tubersol.

Read more


Preserving antibiotic arsenal for TB

Oct. 30, 2013—Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.

Read more


Shortage forces suspension of routine tuberculosis testing

Aug. 29, 2013—Due to a national shortage of the tuberculosis (TB) test solution Tubersol, Occupational Health will temporarily suspend routine annual skin tests, effective Sept. 1, said Patricia Kinman, MSN, FNP-BC, manager of the Vanderbilt Occupational Health Clinic

Read more


Study lays groundwork for rational T cell vaccine design

May. 30, 2013—Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response.

Read more


TB skin testing resumes for VU faculty, staff

May. 9, 2013—Routine TB skin testing, offered through Vanderbilt University Medical Center’s Occupational Health Clinic, has resumed, effective immediately.

Read more


National shortage forces hiatus in routine TB testing

Apr. 11, 2013—Due to an unprecedented national shortage of the tuberculosis (TB) skin testing solution Tubersol, Vanderbilt University Medical Center has temporarily paused routine skin testing of health care workers.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more